ROR1 and ovarian cancer: Moreover, ROR1-positive ovarian CSCs have an enhanced ability to seed metastasis, form tumor spheroids, engraft immune-deficient mice, and migrate better, making ROR1 a prognostic marker for the shorter overall survival of ovarian cancer patients [50].